Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Fabris

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Giornale Di Clinica Medica|February 1, 1981
[Comparative studies of the effects of the diuretics, fenquizone and chlorthalidone, in arterial hypertension]G Bellini, G Battilana, R Carretta, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 1, 1993
Ace inhibition in renal disease: risks and benefitsL Campanacci, B Fabris, F Fischetti, et al.
Giornale Di Clinica Medica|January 1, 1988
[Cardio-regulatory reflexes in patients with alcoholic liver cirrhosis]R Carretta, B Fabris, M Bardelli, et al.
Journal of Cardiovascular Pharmacology|January 1, 1990
Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissueB Fabris, B Z Chen, V Pupic, et al.
Giornale Di Clinica Medica|August 1, 1988
[Distensibility of large arteries after chronic treatment with nicardipine SR in aged hypertensive patients]R Carretta, S Muiesan, M Bardelli, et al.
Il Farmaco; Edizione Scientifica|November 1, 1986
Antihypertensive activity of arylidenaminoguanidine derivativesM G Mamolo, L Vio, B Fabris, et al.
Giornale Di Clinica Medica|November 1, 1990
[Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension]B Fabris, F De Biasi, F Fischetti, et al.
British Journal of Pharmacology|July 1, 1990
Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to ratsB Fabris, H Yamada, R Cubela, et al.
Diabetes & Metabolism|October 18, 2008
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathyM Cocchietto, L Zorzin, B Toffoli, et al.
Clinical Science (London, England : 1979)|March 1, 1983
Baroreflex function after therapy withdrawal in patients with essential hypertensionR Carretta, B Fabris, G Bellini, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Giornale Di Clinica Medica|February 1, 1981
[Comparative studies of the effects of the diuretics, fenquizone and chlorthalidone, in arterial hypertension]G Bellini, G Battilana, R Carretta, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 1, 1993
Ace inhibition in renal disease: risks and benefitsL Campanacci, B Fabris, F Fischetti, et al.
Giornale Di Clinica Medica|January 1, 1988
[Cardio-regulatory reflexes in patients with alcoholic liver cirrhosis]R Carretta, B Fabris, M Bardelli, et al.
Journal of Cardiovascular Pharmacology|January 1, 1990
Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissueB Fabris, B Z Chen, V Pupic, et al.
Giornale Di Clinica Medica|August 1, 1988
[Distensibility of large arteries after chronic treatment with nicardipine SR in aged hypertensive patients]R Carretta, S Muiesan, M Bardelli, et al.
Il Farmaco; Edizione Scientifica|November 1, 1986
Antihypertensive activity of arylidenaminoguanidine derivativesM G Mamolo, L Vio, B Fabris, et al.
Giornale Di Clinica Medica|November 1, 1990
[Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension]B Fabris, F De Biasi, F Fischetti, et al.
British Journal of Pharmacology|July 1, 1990
Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to ratsB Fabris, H Yamada, R Cubela, et al.
Diabetes & Metabolism|October 18, 2008
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathyM Cocchietto, L Zorzin, B Toffoli, et al.
Clinical Science (London, England : 1979)|March 1, 1983
Baroreflex function after therapy withdrawal in patients with essential hypertensionR Carretta, B Fabris, G Bellini, et al.
Pageof 8